← All trials
NCT05073679
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2022
- Primary completion
- Feb 28, 2023
- Completion date
- Aug 31, 2023
- First posted
- Oct 11, 2021
- Last posted
- Oct 11, 2021
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Pennsylvania State UniversityLead sponsor
- Pennsylvania State UniversitySponsor investigator
- Children's Miracle NetworkCollaborator
- Pennsylvania State UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.